Sign inJoin waitlistJoin the waitlist

David Kosoff

Leader, Biospecimen Disease Oriented Team · University of Wisconsin Carbone Cancer Center

Credentials: · · · · ·

History

University of Wisconsin Hospitals and Clinics · University of Wisconsin–Madison, Department of Medicine
Present
University of Wisconsin Hospitals and Clinics
Present

University of Wisconsin Hospitals and Clinics
2019–2021
Hematology and Medical Oncology
University of Wisconsin Hospitals and Clinics
2012–2019
University of Wisconsin Carbone Cancer Center
Internal Medicine
University of Wisconsin Hospitals and Clinics
2012–2015
University of Illinois College of Medicine
2008–2012

Research

PARP inhibitors in metastatic prostate cancer
Review · Frontiers in Oncology · 2023 · 69 citations
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels
Annals of Oncology · 2023 · 62 citations
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer
Journal of Clinical Investigation · 2022 · 36 citations

Joshua Lang
20 papers · 1 as a fellow
Shuang Zhao
13 papers
Marina Sharifi
10 papers · 7 as a resident
Nan Sethakorn
8 papers · 6 as a fellow
AT
Amy Taylor
7 papers · 5 as a resident
Grace Blitzer
7 papers · 7 as a resident
Christos Kyriakopoulos
6 papers
HE
Hamid Emamekhoo
6 papers
John Floberg
6 papers
NR
Nicholas Rydzewski
5 papers
Rana McKay
5 papers · 2 as a resident
Andrew Armstrong
4 papers

Grants

Evaluation of Novel Microscale Cell Culture Platform for Translational Drug Development in Prostate Cancer
Department of Veterans Affairs · I01
Contact PI · Wm s. Middleton Memorial Veterans Hosp
2023–2028

Clinical trials

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2039
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Site PI · Recruiting
Alliance for Clinical Trials in Oncology
2022–2027